Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: An open-label, randomised, phase 2 trial

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: LANCET Year:2020 | Volume:395 | Issue:10238 Page(s): 1695-1704

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: An open-label, randomised, phase 2 trial

Author(s)

| Issue Writer Certificate

Keywords

Not Registered.

Abstract

Cites

The Effect of Proposed Drugs in the Treatment of Patients with COVID-19: A Systematic Review

References

No record.

Cite

APA: Copy

. (2020). Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: An open-label, randomised, phase 2 trial. LANCET, 395(10238), 1695-1704. SID. https://sid.ir/paper/754576/en

Vancouver: Copy

. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: An open-label, randomised, phase 2 trial. LANCET[Internet]. 2020;395(10238):1695-1704. Available from: https://sid.ir/paper/754576/en

IEEE: Copy

, “Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: An open-label, randomised, phase 2 trial,” LANCET, vol. 395, no. 10238, pp. 1695–1704, 2020, [Online]. Available: https://sid.ir/paper/754576/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops